I believe reimbursement at current levels in the US is until January next year.
In absolute terms I think treatment of 1.5 doses at about $15,000 per dose is not a major budget component.In fact there has been a rally in some US healthcare stocks as Obama's healthcare plan seems to have been derailed to an extent.
Nevertheless it is a process that needs to be gone through.
Always seek independent financial advice before making an investment decision
SRX Price at posting:
$4.57 Sentiment: LT Buy Disclosure: Held